🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/03/2003 | 52,05 | 53,02 | 51,69 | 52,27 | -1,03% | 2,57% | 5.769.345 |
| 28/03/2003 | 52,55 | 53,19 | 51,99 | 52,81 | +0,51% | 2,27% | 4.441.634 |
| 27/03/2003 | 51,77 | 53,01 | 51,65 | 52,55 | +1,10% | 2,62% | 5.134.257 |
| 26/03/2003 | 52,48 | 52,83 | 51,89 | 51,98 | -1,86% | 1,80% | 6.585.632 |
| 25/03/2003 | 52,16 | 53,29 | 51,97 | 52,96 | +1,56% | 2,54% | 6.623.046 |
| 24/03/2003 | 53,66 | 53,66 | 51,77 | 52,15 | -3,27% | 3,52% | 5.978.945 |
| 21/03/2003 | 52,89 | 54,25 | 52,84 | 53,91 | +2,75% | 2,65% | 7.512.693 |
| 20/03/2003 | 51,97 | 52,56 | 51,61 | 52,47 | +0,97% | 1,82% | 6.572.742 |
| 19/03/2003 | 50,86 | 52,22 | 50,86 | 51,97 | +2,72% | 2,68% | 6.097.893 |
| 18/03/2003 | 49,83 | 50,89 | 49,81 | 50,59 | +1,57% | 2,16% | 7.021.600 |
| 17/03/2003 | 48,47 | 49,95 | 48,19 | 49,81 | +2,76% | 3,64% | 6.519.189 |
| 14/03/2003 | 48,77 | 49,52 | 48,28 | 48,47 | -0,61% | 2,54% | 6.184.458 |
| 13/03/2003 | 48,91 | 49,27 | 48,33 | 48,77 | -0,29% | 1,93% | 7.805.504 |
| 12/03/2003 | 48,44 | 48,91 | 48,06 | 48,91 | +0,97% | 1,75% | 6.091.395 |
| 11/03/2003 | 48,45 | 48,72 | 47,61 | 48,44 | -0,82% | 2,28% | 6.114.870 |
| 10/03/2003 | 49,19 | 49,54 | 48,65 | 48,85 | -2,23% | 1,82% | 4.710.760 |
| 07/03/2003 | 48,76 | 50,29 | 48,73 | 49,96 | +0,79% | 3,19% | 5.362.616 |
| 06/03/2003 | 49,26 | 50,09 | 48,92 | 49,57 | +0,15% | 2,36% | 5.663.497 |
| 05/03/2003 | 48,62 | 49,73 | 48,56 | 49,49 | +0,50% | 2,41% | 7.118.854 |
| 04/03/2003 | 50,05 | 50,05 | 49,25 | 49,25 | -1,68% | 1,60% | 5.233.188 |
| 03/03/2003 | 50,91 | 51,26 | 49,73 | 50,09 | -0,49% | 3,00% | 4.775.107 |
| 28/02/2003 | 50,38 | 50,60 | 49,99 | 50,33 | -0,09% | 1,21% | 5.881.166 |
| 27/02/2003 | 49,71 | 50,94 | 49,71 | 50,38 | +1,34% | 2,48% | 5.010.383 |
| 26/02/2003 | 50,33 | 50,89 | 49,46 | 49,71 | -1,23% | 2,84% | 4.807.595 |
| 25/02/2003 | 49,62 | 50,61 | 49,24 | 50,33 | +0,55% | 2,77% | 5.411.558 |
| 24/02/2003 | 50,94 | 51,05 | 49,62 | 50,06 | -2,51% | 2,81% | 5.878.232 |
| 21/02/2003 | 50,72 | 51,91 | 50,48 | 51,35 | +0,81% | 2,82% | 5.254.882 |
| 20/02/2003 | 51,81 | 52,07 | 50,73 | 50,94 | -1,80% | 2,60% | 4.237.588 |
| 19/02/2003 | 52,40 | 52,55 | 51,36 | 51,87 | -0,98% | 2,28% | 4.069.279 |
| 18/02/2003 | 52,32 | 52,91 | 51,96 | 52,39 | +1,84% | 1,82% | 4.822.058 |